01 3ALBUMIN (HUMAN)
02 1ALPHA1-PROTEINASE INHIBITOR (HUMAN)
03 3FIBRINOGEN (HUMAN)
04 2HEPATITIS B IMMUNOGLOBULIN (HUMAN)
05 3IMMUNOGLOBULIN (HUMAN)
06 1RABIES IMMUNOGLOBULIN (HUMAN)
07 1TETANUS IMMUNOGLOBULIN (HUMAN)
08 3THROMBIN (HUMAN)
01 1POWDER FOR SOLUTION
02 16SOLUTION
01 11000MG/VIAL
02 11000UNIT/2ML
03 210G/100ML
04 1110UNIT/0.5ML
05 1160MG/2ML
06 118%
07 1220UNIT/ML
08 125%
09 12500UNIT/5ML
10 1250UNIT/ML
11 1300UNIT/ML
12 1400MG/5ML
13 15%
14 1500UNIT/1ML
15 150MG/ML
16 180MG/1ML
01 1ALBUMIN (HUMAN) 25% SOLUTION USP
02 1ALBUMIN (HUMAN) 5% SOLUTION, USP
03 1GAMASTAN
04 1GAMUNEX
05 2HYPERHEP B
06 1HYPERRAB
07 1HYPERTET
08 1IGIVNEX
09 1PLASBUMIN-5
10 1PROLASTIN-C
11 6VISTASEAL
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 50MG/ML
Packaging : 50ML/250ML
Brand Name : PLASBUMIN-5
Approval Date :
Application Number : 2189100
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 5%
Packaging : 50/250/500ML
Brand Name : ALBUMIN (HUMAN) 5% SOLUTION, ...
Approval Date :
Application Number : 2223694
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 25%
Packaging : 50ML/100ML
Brand Name : ALBUMIN (HUMAN) 25% SOLUTION ...
Approval Date :
Application Number : 2223708
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ALPHA1-PROTEINASE INHIBITOR (HUMAN)
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1000MG/VIAL
Packaging : 20ML
Brand Name : PROLASTIN-C
Approval Date :
Application Number : 2204606
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 10G/100ML
Packaging : 25/50/100/200ML
Brand Name : GAMUNEX
Approval Date :
Application Number : 2247724
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
Dosage Form : SOLUTION
Dosage Strength : 220UNIT/ML
Packaging :
Brand Name : HYPERHEP B
Approval Date :
Application Number : 2520001
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
Dosage Form : SOLUTION
Dosage Strength : 110UNIT/0.5ML
Packaging :
Brand Name : HYPERHEP B
Approval Date :
Application Number : 2520125
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 80MG/1ML
Packaging :
Brand Name : VISTASEAL
Approval Date :
Application Number : 2514222
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 160MG/2ML
Packaging :
Brand Name : VISTASEAL
Approval Date :
Application Number : 2514230
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 400MG/5ML
Packaging :
Brand Name : VISTASEAL
Approval Date :
Application Number : 2514257
Regulatory Info : Schedule D
Registration Country : Canada
Grifols International is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of THE PRODUCTION OF STERILE WATER FOR INJECTION PACKAGED IN SINGLE DOSE TYPE I GLASS VIALS (SOLVENT FOR PARENTERAL USE) bulk with DMF offered by Grifols International
LOOKING FOR A SUPPLIER?